MeSH tree: D10.532.350
U.S. medical organizations are looking to reduce deaths caused by heart disease, the nation's No. 1 killer, with new guidelines that reframe prevention as a lifelong battle that begins with testing in childhood.
Apr 11, 2026
0
7
Elevated lipoprotein(a) [Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population. Despite therapeutic ...
Mar 16, 2026
0
11
Researchers at Keele University have said that more targeted use of testing for a common molecule could help to improve predictions of cardiovascular disease outcomes in patients at greatest risk.
Jan 29, 2026
0
4
Unhealthy cholesterol levels are a major risk factor for heart disease and stroke. When lifestyle changes like diet and exercise aren't enough to lower cholesterol, medications can help. A new national survey commissioned ...
Jan 27, 2026
0
154
Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular events in initially healthy women.
Heart disease is the leading cause of death in the United States.
Dec 22, 2025
0
17
Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial hypercholesterolemia (HeFH), a genetic disorder that leads to high levels of LDL cholesterol.
Routine testing for a specific lipoprotein known as Lp(a) would be a cost-saving way to significantly reduce the risk of cardiovascular disease and save lives, according to an international research taskforce led by Monash ...
Aug 20, 2025
0
19
A Monash-led international study has found a cholesterol-lowering drug may offer a more effective and convenient way to protect people at high risk of heart attack and stroke.
May 9, 2025
0
162
For almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of cardiovascular disease.
Apr 28, 2025
0
128
